JG
ORIAW

Jefferies Group’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Jefferies Group’s Portfolio ORIAW Stock Details ORIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.38K Hold
18,348
– – ﹤0.01% 1584
2022
Q2 		$2.76K Hold
18,348
– – ﹤0.01% 1493
2022
Q1 		$6.79K Hold
18,348
– – ﹤0.01% 1479
2021
Q4 		$17.6K Buy
+18,348
New +$19.2K ﹤0.01% 1563

Other funds holding ORIAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Jefferies Group's ORIAW Position: Q3 2022 in Review

Jefferies Group held its Orion Biotech Opportunities Corp. Warrant (ORIAW) position steady in Q3 2022 at 18,348 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1584.

Jefferies Group first reported a position in ORIAW in Q4 2021 and has held it in 4 quarters since. The position peaked at $17.6K in Q4 2021. 31 funds tracked by Wall St. Rank hold ORIAW as of Q3 2022.

  • Jefferies Group held 18,348 shares of Orion Biotech Opportunities Corp. Warrant worth $2.38K as of Q3 2022.
  • Jefferies Group left its Orion Biotech Opportunities Corp. Warrant share count unchanged in Q3 2022.
  • Orion Biotech Opportunities Corp. Warrant made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1584 holding.
  • Jefferies Group first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2021 and has held it in 4 quarters since.
  • Jefferies Group's Orion Biotech Opportunities Corp. Warrant position peaked at $17.6K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.